Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$848,747
-$125,629 QoQ
Shares Held
35,247
+1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,422
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWE & RUSLING INC holds $48,551,537 across 10 Drug Manufacturers - General names. PFE ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
97,901 | $24,635,807 | |
| 2 | AZN |
Astrazeneca PLC
|
42,193 | $8,000,635 | |
| 3 | JNJ |
Johnson & Johnson
|
29,374 | $7,460,114 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,744 | $3,179,604 | |
| 5 | AMGN |
Amgen Inc
|
4,998 | $1,809,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,076 | $1,290,586 | |
| 7 | PFE |
Pfizer Inc
This page
|
35,247 | $848,747 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,437 | $686,910 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $848,747 | 35,247 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $974,376 | 34,700 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,022,593 | 41,068 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $779,178 | 30,580 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $717,479 | 29,599 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $729,792 | 28,800 | Shares | Sole | 2025-06-17 | |
| 2024-12-31 | $701,851 | 26,455 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,010,932 | 34,932 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,104,258 | 39,466 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,080,446 | 38,935 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,509,027 | 52,415 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,070,637 | 62,425 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,456,166 | 66,962 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,821,768 | 69,161 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,770,956 | 73,594 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,400,502 | 77,708 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,805,107 | 72,575 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,564,478 | 49,536 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,818,409 | 64,664 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,731,315 | 110,005 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,448,316 | 368,956 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $14,735,610 | 406,724 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $15,411,758 | 418,684 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $15,444,665 | 420,836 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $13,952,123 | 426,670 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $9,643,931 | 295,464 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||